N-Chloracetyl-3,4-dihydroxy-phenaethylamin | 17639-51-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: N-Chloracetyl-3,4-dihydroxy-phenaethylamin
• 英文别名: N-Chloracetyl-β-(3,4-dihydroxyphenyl)ethylamin；2-chloro-N-[2-(3,4-dihydroxyphenyl)ethyl]acetamide
• CAS: 17639-51-9
• 化学式: C₁₀H₁₂ClNO₃
• 分子量: 229.663
• InChiKey: FYRCVFGLEQJPIE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  69.6
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
  申请人：Cornell Research Foundation, INC.

  公开号：EP1477165A2

  公开（公告）日：2004-11-17

  Inflammation in particular contac dermatitis, rheumatoid arthritis and allograft rejection caused by overproduction of nitric oxide in immune cells is prevented or treated with at least one tetrahydrobiopterin synthesis antagonist. The antagonist can be a guanosine triphosphate pathway tetrahydrobiopterin synthesis antagonist and/or a pterin salvage pathway tetrahydrobiopterin synthesis antagonists. Selected from oxidiyed pterins and reduced pterins substituted pyrimidines acetylserotonin, N-acetyldopamine, N-acetyl-m-tyramine, N-chloroacetylldopamine, N-chloroacetylserotonin, N-menthoxyacetyldopamine and N-methoxyacetylserotonin. Unwanted counterproductive or side effects can be eliminated or ameliorated by administration additionally of levodopa additionally of levodopa with or without carbidopa and of L-5-hydroxytryptophane.

  至少一种四氢生物蝶呤合成拮抗剂可预防或治疗因免疫细胞过量产生一氧化氮而引起的炎症，特别是传染性皮炎、类风湿性关节炎和异体移植排斥反应。拮抗剂可以是三磷酸鸟苷途径四氢生物蝶呤合成拮抗剂和/或蝶呤挽救途径四氢生物蝶呤合成拮抗剂。从氧化型蝶呤和还原型蝶呤中选择取代嘧啶的乙酰丝氨酸、N-乙酰多巴胺、N-乙酰基-m-酪胺、N-氯乙酰多巴胺、N-氯乙酰丝氨酸、N-甲氧基乙酰多巴胺和 N-甲氧基乙酰丝氨酸。通过额外服用左旋多巴、左旋多巴加或不加卡比多巴和 L-5-羟色胺，可以消除或减轻不必要的反作用或副作用。
• Methods for treating pain
  申请人：Woolf J. Clifford

  公开号：US20050197341A1

  公开（公告）日：2005-09-08

  The present invention features methods and compositions for preventing, reducing, or treating a traumatic, metabolic or toxic peripheral nerve lesion or pain including, for example, neuropathic pain, inflammatory and nociceptive pain by administering to a mammal in need thereof a compound that reduces the expression or activity of BH4. According to this invention, this reduction may be achieved by reducing the enzyme activity of any of the BH4 synthetic enzymes, such as GTP cyclohydrolase (GTPCH), sepiapterin reductase (SPR), or dihydropteridine reductase (DHPR); by antagonizing the cofactor function of BH4 on BH4-dependent enzymes; or by blocking BH4 binding to membrane bound receptors. The compounds of the invention may be administered alone or in combination with a second therapeutic agent. The invention also provides methods for diagnosing pain or a peripheral nerve lesion in a mammal by measuring the levels of BH4 or its metabolites in biological sample. Alternatively, pain or a peripheral nerve lesion may be diagnosed by measuring the levels or activity of any one of the BH4 synthetic enzymes in tissue samples of a mammal. Also disclosed are screening methods that make use of BH4 or BH4 synthetic enzymes, BH4-dependent enzymes, and BH4-binding receptors for the identification of novel therapeutics for the treatment, prevention, or reduction of pain.

  本发明的特征是，通过向需要的哺乳动物施用降低BH4表达或活性的化合物，预防、减轻或治疗创伤性、代谢性或毒性周围神经病变或疼痛，包括例如神经病理性疼痛、炎症性和痛觉疼痛的方法和组合物。根据本发明，这种降低可通过降低任何一种 合成酶的酶活性来实现，如 GTP 环氢酶 (GTPCH)、sepiapterin 还原酶 (SPR) 或二氢吡啶还原酶 (DHPR)；通过拮抗 对 依赖性酶的辅助因子功能；或通过阻断 与膜结合受体的结合。本发明的化合物可单独给药，也可与第二种治疗剂联合给药。本发明还提供了通过测量生物样本中 或其代谢物的水平来诊断哺乳动物疼痛或外周神经损伤的方法。另外，也可以通过测量哺乳动物组织样本中任何一种 合成酶的水平或活性来诊断疼痛或周围神经病变。还公开了利用 或 合成酶、 依赖性酶和 结合受体鉴定治疗、预防或减轻疼痛的新型疗法的筛选方法。
• BLOCKING INDUCTION OF TETRAHYDROBIOPTERIN TO BLOCK INDUCTION OF NITRIC OXIDE SYNTHESIS
  申请人：CORNELL RESEARCH FOUNDATION, INC.

  公开号：EP0729355A1

  公开（公告）日：1996-09-04
• EP0729355A4
  申请人：——

  公开号：EP0729355A4

  公开（公告）日：2002-05-02
• METHODS FOR TREATING PAIN
  申请人：THE GENERAL HOSPITAL CORPORATION

  公开号：EP1696877A2

  公开（公告）日：2006-09-06